Oxygen delivery and cardiac output during exercise following oral phosphate-glucose

E. T. Mannix, J. M. Stager, A. Harris, M. O. Farber

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Phosphate has been proposed as an ergogenic aid since it may enhance O2 delivery and cardiac work efficiency by increasing plasma phosphate (P Pi), red blood cell phosphate (RBC Pi), 2,3-diphosphoglycerate (DPG), RBC adenosine triphosphate (ATP), and P50. In 10 normal, fasting males we measured cardiac output (Q) by CO2 rebreathing, heart rate (HR), O2 deficit (O2DEF), and O2 con-sumption (VO2) during cycle ergometer exercise (60% of peak VO2). Stroke volume (SV) and arteriovenous O2 difference (A-VO2) were calculated. Following a baseline blood sample (BASE) for P Pi, RBC Pi, DPG, RBC ATP, and P50 (3 h before exercise), a single oral dose of dicalcium phosphate (129 mmol) and glucose (500 ml/10% sol, PHOS), or placebo (PLA), was administered in a random, crossover, double-blind fashion. Blood sampling was repeated immediately before and after exercise (PRE-EX and POST-EX). PHOS induced increases in P Pi (3.87 to 4.35 mg · dl−1, P < 0.05), RBC Pi (3.86 to 4.63 mg · dl−1, P = 0.08), DPG (11.8 to 13.1 μmol · g−1 Hb, P < 0.05), RBC ATP (4.2 to 4.4 μmol · g−1 Hb, P < 0.05), and P50 (26.8 to 27.9 mm Hg, P < 0.05) from BASE to PRE-EX. All variables remained elevated through the exercise period, as evidenced by higher levels than BASE at POST-EX (P < 0.05). However, P50 was not different across conditions at PRE-EX (PHOS P50 = 27.9, PLA P50 = 28.3 mm Hg) or POST-EX (PHOS P50 = 28.0, PLA P50 = 28.1 mm Hg). No differences in Q, SV, HR, O2DEF, VO2, or A-VO2 were noted across conditions. Thus, the acute alterations of the hemato-logical parameters resulting from PHOS do not affect O2 delivery or cardiac output during submaximal exercise.

Original languageEnglish (US)
Pages (from-to)341-347
Number of pages7
JournalMedicine and Science in Sports and Exercise
Volume22
Issue number3
StatePublished - Jun 1990

Fingerprint

Cardiac Output
Phosphates
Oxygen
Glucose
Adenosine Triphosphate
Placebos
Stroke Volume
Heart Rate
2,3-Diphosphoglycerate
Polymethyl Methacrylate
Fasting
Erythrocytes
hemoglobin P

Keywords

  • 3-dpg
  • Cardiac work efficiency
  • Ergogenic aid
  • Hemoglobin
  • Oxygen affinity, 2
  • Oxygen deficit

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Oxygen delivery and cardiac output during exercise following oral phosphate-glucose. / Mannix, E. T.; Stager, J. M.; Harris, A.; Farber, M. O.

In: Medicine and Science in Sports and Exercise, Vol. 22, No. 3, 06.1990, p. 341-347.

Research output: Contribution to journalArticle

@article{d86c8f0e44d640788441e26275bf33d6,
title = "Oxygen delivery and cardiac output during exercise following oral phosphate-glucose",
abstract = "Phosphate has been proposed as an ergogenic aid since it may enhance O2 delivery and cardiac work efficiency by increasing plasma phosphate (P Pi), red blood cell phosphate (RBC Pi), 2,3-diphosphoglycerate (DPG), RBC adenosine triphosphate (ATP), and P50. In 10 normal, fasting males we measured cardiac output (Q) by CO2 rebreathing, heart rate (HR), O2 deficit (O2DEF), and O2 con-sumption (VO2) during cycle ergometer exercise (60{\%} of peak VO2). Stroke volume (SV) and arteriovenous O2 difference (A-VO2) were calculated. Following a baseline blood sample (BASE) for P Pi, RBC Pi, DPG, RBC ATP, and P50 (3 h before exercise), a single oral dose of dicalcium phosphate (129 mmol) and glucose (500 ml/10{\%} sol, PHOS), or placebo (PLA), was administered in a random, crossover, double-blind fashion. Blood sampling was repeated immediately before and after exercise (PRE-EX and POST-EX). PHOS induced increases in P Pi (3.87 to 4.35 mg · dl−1, P < 0.05), RBC Pi (3.86 to 4.63 mg · dl−1, P = 0.08), DPG (11.8 to 13.1 μmol · g−1 Hb, P < 0.05), RBC ATP (4.2 to 4.4 μmol · g−1 Hb, P < 0.05), and P50 (26.8 to 27.9 mm Hg, P < 0.05) from BASE to PRE-EX. All variables remained elevated through the exercise period, as evidenced by higher levels than BASE at POST-EX (P < 0.05). However, P50 was not different across conditions at PRE-EX (PHOS P50 = 27.9, PLA P50 = 28.3 mm Hg) or POST-EX (PHOS P50 = 28.0, PLA P50 = 28.1 mm Hg). No differences in Q, SV, HR, O2DEF, VO2, or A-VO2 were noted across conditions. Thus, the acute alterations of the hemato-logical parameters resulting from PHOS do not affect O2 delivery or cardiac output during submaximal exercise.",
keywords = "3-dpg, Cardiac work efficiency, Ergogenic aid, Hemoglobin, Oxygen affinity, 2, Oxygen deficit",
author = "Mannix, {E. T.} and Stager, {J. M.} and A. Harris and Farber, {M. O.}",
year = "1990",
month = "6",
language = "English (US)",
volume = "22",
pages = "341--347",
journal = "Medicine and Science in Sports and Exercise",
issn = "0195-9131",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Oxygen delivery and cardiac output during exercise following oral phosphate-glucose

AU - Mannix, E. T.

AU - Stager, J. M.

AU - Harris, A.

AU - Farber, M. O.

PY - 1990/6

Y1 - 1990/6

N2 - Phosphate has been proposed as an ergogenic aid since it may enhance O2 delivery and cardiac work efficiency by increasing plasma phosphate (P Pi), red blood cell phosphate (RBC Pi), 2,3-diphosphoglycerate (DPG), RBC adenosine triphosphate (ATP), and P50. In 10 normal, fasting males we measured cardiac output (Q) by CO2 rebreathing, heart rate (HR), O2 deficit (O2DEF), and O2 con-sumption (VO2) during cycle ergometer exercise (60% of peak VO2). Stroke volume (SV) and arteriovenous O2 difference (A-VO2) were calculated. Following a baseline blood sample (BASE) for P Pi, RBC Pi, DPG, RBC ATP, and P50 (3 h before exercise), a single oral dose of dicalcium phosphate (129 mmol) and glucose (500 ml/10% sol, PHOS), or placebo (PLA), was administered in a random, crossover, double-blind fashion. Blood sampling was repeated immediately before and after exercise (PRE-EX and POST-EX). PHOS induced increases in P Pi (3.87 to 4.35 mg · dl−1, P < 0.05), RBC Pi (3.86 to 4.63 mg · dl−1, P = 0.08), DPG (11.8 to 13.1 μmol · g−1 Hb, P < 0.05), RBC ATP (4.2 to 4.4 μmol · g−1 Hb, P < 0.05), and P50 (26.8 to 27.9 mm Hg, P < 0.05) from BASE to PRE-EX. All variables remained elevated through the exercise period, as evidenced by higher levels than BASE at POST-EX (P < 0.05). However, P50 was not different across conditions at PRE-EX (PHOS P50 = 27.9, PLA P50 = 28.3 mm Hg) or POST-EX (PHOS P50 = 28.0, PLA P50 = 28.1 mm Hg). No differences in Q, SV, HR, O2DEF, VO2, or A-VO2 were noted across conditions. Thus, the acute alterations of the hemato-logical parameters resulting from PHOS do not affect O2 delivery or cardiac output during submaximal exercise.

AB - Phosphate has been proposed as an ergogenic aid since it may enhance O2 delivery and cardiac work efficiency by increasing plasma phosphate (P Pi), red blood cell phosphate (RBC Pi), 2,3-diphosphoglycerate (DPG), RBC adenosine triphosphate (ATP), and P50. In 10 normal, fasting males we measured cardiac output (Q) by CO2 rebreathing, heart rate (HR), O2 deficit (O2DEF), and O2 con-sumption (VO2) during cycle ergometer exercise (60% of peak VO2). Stroke volume (SV) and arteriovenous O2 difference (A-VO2) were calculated. Following a baseline blood sample (BASE) for P Pi, RBC Pi, DPG, RBC ATP, and P50 (3 h before exercise), a single oral dose of dicalcium phosphate (129 mmol) and glucose (500 ml/10% sol, PHOS), or placebo (PLA), was administered in a random, crossover, double-blind fashion. Blood sampling was repeated immediately before and after exercise (PRE-EX and POST-EX). PHOS induced increases in P Pi (3.87 to 4.35 mg · dl−1, P < 0.05), RBC Pi (3.86 to 4.63 mg · dl−1, P = 0.08), DPG (11.8 to 13.1 μmol · g−1 Hb, P < 0.05), RBC ATP (4.2 to 4.4 μmol · g−1 Hb, P < 0.05), and P50 (26.8 to 27.9 mm Hg, P < 0.05) from BASE to PRE-EX. All variables remained elevated through the exercise period, as evidenced by higher levels than BASE at POST-EX (P < 0.05). However, P50 was not different across conditions at PRE-EX (PHOS P50 = 27.9, PLA P50 = 28.3 mm Hg) or POST-EX (PHOS P50 = 28.0, PLA P50 = 28.1 mm Hg). No differences in Q, SV, HR, O2DEF, VO2, or A-VO2 were noted across conditions. Thus, the acute alterations of the hemato-logical parameters resulting from PHOS do not affect O2 delivery or cardiac output during submaximal exercise.

KW - 3-dpg

KW - Cardiac work efficiency

KW - Ergogenic aid

KW - Hemoglobin

KW - Oxygen affinity, 2

KW - Oxygen deficit

UR - http://www.scopus.com/inward/record.url?scp=0025373075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025373075&partnerID=8YFLogxK

M3 - Article

C2 - 2381302

AN - SCOPUS:0025373075

VL - 22

SP - 341

EP - 347

JO - Medicine and Science in Sports and Exercise

JF - Medicine and Science in Sports and Exercise

SN - 0195-9131

IS - 3

ER -